Association between TB related symptoms and HIV status among the 245 survey cases with known HIV status.

Total per-test unit costs during the experiment, weighted to account for actual different unit costs by workloads, and costs associated with overtime work and laboratory...

Model-generated clinical and economic outcomes of TB diagnostic strategies.

Multiplex ASO-PCR primers.

Clinical characteristics of 49 studied patients.

Summary of model inputs.

ObjectiveTo compare the population-level impact of two World Health Organization-endorsed strategies for improving the diagnosis of tuberculosis (TB): same-day microscopy and...

(ZIP)

Diagnostic accuracy of smear and Xpert MTB/RIF among the MGIT and/or LJ culture positive (n = 328) tuberculosis participants.

Cumulative Ten-Year Projected Burden of TB (2013–2022) in an African Area with a 2003 Population of 10 Million Adults.

Temporal trends in TB testing in the smear/culture and Xpert® based algorithms.

Optimal strategy according to the willingness-to-pay threshold (US$/QALYs) in one way sensitivity analysis.

Clinical characteristics of patients with false positivity in either real time TB PCR or Xpert MTB/RIF assay.

Model parameters of utility.

Diagnostic performance of GeneXpert against culture and smear as the reference standard.

Xpert MTB/RIF G4 vs Ultra discordant results.

Characteristics of patients with NTM or MTB positive culture treated with an anti-TB treatment.

Characteristics of the included studies.

The characteristics of intervention and control areas.

Differences in yield of Xpert MTB/RIF assay test by sample or category of sample.